Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
539.11
470.45
565.50
548.25
551.26
583.23
636.20
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
539.11
470.45
565.50
548.25
551.26
583.23
636.20
Raw Material Cost
293.39
279.72
317.36
302.83
286.59
271.73
311.20
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.92
0.68
0.00
2.20
0.14
1.09
0.99
Selling and Distribution Expenses
149.95
127.21
142.66
159.15
183.89
213.69
237.16
Other Expenses
1.07
2.69
1.82
1.21
1.39
4.04
1.92
Total Expenditure (Excl Depreciation)
454.91
434.48
478.26
476.27
484.55
526.95
568.50
Operating Profit (PBDIT) excl Other Income
84.2
36
87.2
72
66.7
56.3
67.69999999999999
Other Income
14.91
21.41
10.59
17.29
7.93
28.87
4.76
Operating Profit (PBDIT)
90.47
63.00
111.79
103.53
88.34
94.87
86.80
Interest
0.92
0.68
0.00
2.20
0.14
1.09
0.99
Exceptional Items
17.63
-31.71
29.13
5.00
3.56
-8.87
5.77
Gross Profit (PBDT)
245.71
190.73
248.13
245.42
264.67
311.50
325.00
Depreciation
0.00
22.73
22.73
22.67
22.67
22.55
22.55
Profit Before Tax
107.18
7.87
118.19
83.66
69.10
62.37
69.03
Tax
10.46
5.85
6.74
7.65
7.02
10.88
8.73
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
94.93
133.14
109.34
74.17
60.25
49.27
58.51
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
94.93
133.14
109.34
74.17
60.25
49.27
58.51
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.74
1.29
1.16
1.32
1.68
1.48
1.75
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
96.67
134.43
110.50
75.49
61.93
50.75
60.26
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,387.99
2,293.67
2,157.14
2,047.94
1,934.46
1,950.70
1,893.92
Earnings per share (EPS)
0.04
0.06
0.05
0.03
0.03
0.02
0.03
Diluted Earnings per share
0.04
0.06
0.05
0.03
0.03
0.02
0.03
Operating Profit Margin (Excl OI)
14.02%
4.01%
13.88%
11.6%
10.48%
7.45%
9.35%
Gross Profit Margin
19.88%
6.51%
24.92%
19.39%
16.65%
14.56%
14.39%
PAT Margin
17.61%
28.3%
19.34%
13.53%
10.93%
8.45%
9.2%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 14.58% vs -16.80% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -28.05% vs 21.63% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 81.73% vs -58.89% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 28.57% vs 0.00% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Harbin Gloria Pharmaceuticals Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
539.11
0
539.11
Other Operating Income
0.00
0.00
0.00
Total Operating income
539.11
0
539.11
Raw Material Cost
293.39
0
293.39
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.92
0
0.92
Selling and Distribution Expenses
149.95
0
149.95
Other Expenses
1.07
0.00
1.07
Total Expenditure (Excl Depreciation)
454.91
0
454.91
Operating Profit (PBDIT) excl Other Income
84.20
0.00
84.20
Other Income
14.91
0
14.91
Operating Profit (PBDIT)
90.47
0
90.47
Interest
0.92
0
0.92
Exceptional Items
17.63
0
17.63
Gross Profit (PBDT)
245.71
0
245.71
Depreciation
0.00
0
0.00
Profit Before Tax
107.18
0
107.18
Tax
10.46
0
10.46
Provisions and contingencies
0
0
0.00
Profit After Tax
94.93
0
94.93
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
94.93
0
94.93
Share in Profit of Associates
0
0
0.00
Minority Interest
1.74
0
1.74
Other related items
0.00
0.00
0.00
Consolidated Net Profit
96.67
0
96.67
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,387.99
0
2,387.99
Earnings per share (EPS)
0.04
0
0.04
Diluted Earnings per share
0.04
0
0.04
Operating Profit Margin (Excl OI)
14.02%
0%
0.00
14.02%
Gross Profit Margin
19.88%
0%
0.00
19.88%
PAT Margin
17.61%
0%
0.00
17.61%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 53.91 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 14.58% vs -16.80% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -2.21% vs -7.05% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 9.67 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -28.05% vs 21.63% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 56.22% vs 10.93% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.56 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 81.73% vs -58.89% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -5.97% vs 24.27% in Mar 2025
Quarterly - Interest
Interest 0.09 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 28.57% vs 0.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 800.00% vs -98.08% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.02%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
